Literature DB >> 18547659

Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.

Gregory L Willis1, Adelheid M A Kelly, Gerard A Kennedy.   

Abstract

Like enucleation, lateral hypothalamic (LH) lesions sever the connection between the retina and the pineal thereby simulating ambient exposure to constant darkness. While LH lesions have been employed to study either circadian function or Parkinson's disease (PD) independently, the application of such lesions to study circadian involvement specifically in this disease has never been attempted. In the present study, unilateral lesions of the LH, which compromise nigro-striatal dopamine (NSD) function, were combined with enucleation ipsilateral or contralateral to the hemisphere where 6-hydroxydopamine was applied. In addition to the observation that hemi-enucleation produced patterns of motor function that were grossly atypical compared to visually intact rats, hemi-enucleation ipsilateral to the side of NSD system denervation produced impairment of horizontal movement, limb retraction, ambulation and spontaneous or l-dopa induced turning. This impairment was more severe than that seen in rats with unilateral 6-OHDA lesions alone. Furthermore, hemi-enucleation contralateral to the side of unilateral NSD system denervation resulted in significantly improved performance on several parameters. While the rate of mortality in rats receiving unilateral 6-OHDA plus ipsilateral enucleation was similar to that occurring after bilateral lesions, it was not accompanied by severe weight loss and wasting that typically occurs in the acute stages of experimental PD. These results demonstrate the importance of the visual and circadian systems in PD and are consistent with reports that identify impaired circadian involvement as a major component in a wide range of neurological and neuropsychiatric conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547659     DOI: 10.1016/j.bbr.2008.04.017

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  9 in total

Review 1.  The circadian clock and pathology of the ageing brain.

Authors:  Anna A Kondratova; Roman V Kondratov
Journal:  Nat Rev Neurosci       Date:  2012-03-07       Impact factor: 34.870

2.  Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat.

Authors:  Tao Meng; Zhi-Hong Zheng; Ting-Ting Liu; Ling Lin
Journal:  Neurochem Res       Date:  2012-01-18       Impact factor: 3.996

Review 3.  Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?

Authors:  Aleksandar Videnovic; Gregory L Willis
Journal:  Mov Disord       Date:  2016-01-30       Impact factor: 10.338

4.  Variable abnormality of the melanopsin-derived portion of the pupillary light reflex (PLR) in patients with Parkinson's disease (PD) and parkinsonism features.

Authors:  Bruce I Gaynes; Adnaan Zaffer; Raman Yousefzai; Mario Chazaro-Cortes; Kalea Colletta; Sandra L Kletzel; Mary Beth Jost; Youngsook Park; Jasvinder Chawla; Mark V Albert; Ting Xiao
Journal:  Neurol Sci       Date:  2021-05-04       Impact factor: 3.307

5.  Circadian Dysregulation in Parkinson's Disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2016-11-12

Review 6.  Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.

Authors:  Santiago Pérez-Lloret; Daniel P Cardinali
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

7.  Detection of Parkinson's Disease Through Automated Pupil Tracking of the Post-illumination Pupillary Response.

Authors:  Thasina Tabashum; Adnaan Zaffer; Raman Yousefzai; Kalea Colletta; Mary Beth Jost; Youngsook Park; Jasvinder Chawla; Bruce Gaynes; Mark V Albert; Ting Xiao
Journal:  Front Med (Lausanne)       Date:  2021-03-25

8.  Neurochemical Systems of the Retina Involved in the Control of Movement.

Authors:  Gregory L Willis; Christopher B Freelance
Journal:  Front Neurol       Date:  2017-07-05       Impact factor: 4.003

9.  Parkinson's disease, lights and melanocytes: looking beyond the retina.

Authors:  Gregory L Willis; Cleo Moore; Stuart Maxwell Armstrong
Journal:  Sci Rep       Date:  2014-01-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.